glp-1 autoimmune disease Agonists in The Beneficial Effects of GLP-1

More frequently than standard Hashimoto's monitoring

10.1210/edrv.18.6.0318 Endocr Rev

Landmark analysis: a primer

Both use the same active ingredients as the brand-name injections

GLP-1 receptor agonists, such as semaglutide, marketed as Ozempic (subcutaneous, once weekly) and Rybelsus (oral, once daily) for type 2 diabetes mellitus, and as Wegovy (subcutaneous, once weekly) for obesity irrespective of diabetes status, have become a cornerstone therapy owing to their efficacy in improving glycemic control and promoting weight loss [5]

Find out if they are safe, as well as how to spot them, in our article about sunscreen safety and effectiveness